Lantern Pharma
Stock Forecast, Prediction & Price Target
Lantern Pharma Financial Estimates
Lantern Pharma Revenue Estimates
Lantern Pharma EBITDA Estimates
Lantern Pharma Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $1.95M Low: $1.95M High: $1.95M avg. 0% | Avg: $14.6M Low: $14.6M High: $14.6M avg. 648.71% | Avg: $33.8M Low: $33.8M High: $33.8M avg. 131.50% |
Net Income
% change YoY
| $-12.29M N/A | $-14.08M -14.57% | $-15.96M -13.30% | Avg: $-27.65M Low: $-21.90M High: $-19.73M avg. -73.27% | Avg: $-18.58M Low: $-12.36M High: $-12.36M avg. 32.79% | Avg: $-13.87M Low: $-13.87M High: $-13.87M avg. 25.33% | Avg: $-9.10M Low: $-9.10M High: $-9.10M avg. 34.37% |
EBITDA
% change YoY
| $-12.58M N/A | $-14.42M -14.60% | $-15.78M -9.45% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.13 N/A | -$1.3 -15.04% | -$1.47 -13.07% | Avg: -$1.92 Low: -$2.02 High: -$1.82 avg. -30.61% | Avg: -$1.14 Low: -$1.14 High: -$1.14 avg. 40.62% | Avg: -$1.28 Low: -$1.28 High: -$1.28 avg. -12.28% | Avg: -$0.84 Low: -$0.84 High: -$0.84 avg. 34.37% |
Operating Expenses
% change YoY
| $12.59M N/A | $14.43M 14.62% | $17.87M 23.86% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Lantern Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 4.80% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -21.90M, average is -27.65M and high is -19.73M.
What is Lantern Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 195.05% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Lantern Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 8.02% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.02, average is -$1.92 and high is $-1.82.